The concept of major and minor cannabinoids came from the different cannabis plant characteristics. Major cannabinoids are originally known to be CBD (cannabidiol), CBG (cannabigerol) and – Delta 9 tetrahydrocannabinol (in the following we will call it short name delta 9) and they are most actively produced phytocannabinoids present in the hemp plant.
However, due to the many breeding programs, the strains are categorized according to the amount of the cannabinoids Delta 9 and CBD present in the strain. The Delta 9 dominant strains with low CBD contents induce intoxicating, psychotropic effects including euphoria, enhanced sensory perception and memory loss. In contrast, CBD dominant strains with low Delta 9 contents are non-psychotropic. The positive effects of CBD are known to reduce inflammation, help sleep and relief pain. To summarize, the major legal cannabinoids are CBD and CBG. CBD, CBG exists in the raw cannabis in its acidic form (ex. CBDA, CBGA). It is non-intoxicating like CBD, as both molecules work indirectly on neurological systems. CBG offers medical benefits without the intoxicating side of Delta 9. Previously known as a manor cannabinoid, it is now recognized as a major one and is globally used in hemp products.
Minor (or rare) cannabinoids have many properties that are beneficial to our health, and they are known to be safer than Delta 9 containing strains because of the lack of intoxicating effects. There are over 100 minor cannabinoids. However, only a few are better known to a wide audience. Generally industrial hemp contains small amounts of minor cannabinoids. The most known minor cannabinoids are: CBN, CBC, and CBDV.